[Acute complications during treatment of virilizing congenital adrenal hyperplasia deficiency due to 21-hydroxylase].
D000293:Adolescent; D000312:Adrenal Hyperplasia, Congenital / Q000150:complications* / Q000188:drug therapy* / Q000401:mortality; D000328:Adult; D001827:Body Height; D002648:Child; D002675:Child, Preschool; D003681:Dehydration / Q000517:prevention & control; D005260:Female; D005947:Glucose / Q000627:therapeutic use*; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007223:Infant; D007231:Infant, Newborn; D008901:Mineralocorticoids / Q000627:therapeutic use*; D006899:Mixed Function Oxygenases; D010477:Perfusion; D011279:Pregnanetriol / Q000652:urine; D012640:Seizures / Q000517:prevention & control; D012965:Sodium Chloride / Q000627:therapeutic use* / Q000652:urine; D014839:Vomiting / Q000517:prevention & control
D008901:Mineralocorticoids; D011279:Pregnanetriol; D012965:Sodium Chloride; D006899:Mixed Function Oxygenases; D005947:Glucose; D006854:Hydrocortisone
Les accidents aigus au cours du traitement de l'hyperplasie surrénale congénitale virilisante par défaut de 21-hydroxylase.